PMID- 16457806 OWN - NLM STAT- MEDLINE DCOM- 20060418 LR - 20131121 IS - 0014-2999 (Print) IS - 0014-2999 (Linking) VI - 531 IP - 1-3 DP - 2006 Feb 15 TI - (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. PG - 171-5 AB - (-)-Epigallocatechin gallate (EGCG), a flavonoid, is the principal catechin found in green tea and is distributed in the brain after tea consumption. The aim of the present study was to investigate the effects of EGCG in the chick brain under an acute stressful condition and to clarify the mechanism by which EGCG attenuates stress behavior with special reference to gamma-aminobutyric acid (GABA). Intracerebroventricular (i.c.v.) injection of EGCG (50, 100 and 200 microg) suppressed the vocalization which normally occurs during social separation stress. EGCG decreased the time spent in active wakefulness and induced sleep-like behavior in a dose-dependent manner. Additionally, i.c.v. injection of EGCG attenuated plasma corticosterone release under social separation stress. These effects of EGCG on distress-induced vocalization were significantly attenuated by the GABAA receptor antagonist picrotoxin but not by the GABAB receptor antagonist CGP 54626 (3-N-(1-(3,4-dichlorophenyl)ethylamino)-2-hydroxypropyl cyclohexylmethyl phosphinic acid hydrochloride). These results indicate that EGCG has sedative and hypnotic effects in the brain, partially through GABAA receptors, and consequently moderates an acute stress response. FAU - Adachi, Nami AU - Adachi N AD - Laboratory of Advanced Animal and Marine Bioresources, Graduate School of Bioresources and Bioenvironmental Sciences, Kyushu University, Fukuoka 812-8581, Japan. FAU - Tomonaga, Shozo AU - Tomonaga S FAU - Tachibana, Tetsuya AU - Tachibana T FAU - Denbow, D Michael AU - Denbow DM FAU - Furuse, Mitsuhiro AU - Furuse M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060202 PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Antioxidants) RN - 0 (GABA Antagonists) RN - 0 (GABA-B Receptor Antagonists) RN - 0 (Organophosphorus Compounds) RN - 0 (Receptors, GABA-B) RN - 124-87-8 (Picrotoxin) RN - 149184-21-4 (CGP 54626) RN - 8R1V1STN48 (Catechin) RN - BQM438CTEL (epigallocatechin gallate) RN - W980KJ009P (Corticosterone) SB - IM MH - Animals MH - Antioxidants/administration & dosage/pharmacology MH - Brain/*drug effects/physiology/physiopathology MH - Catechin/administration & dosage/*analogs & derivatives/pharmacology MH - Chickens MH - Corticosterone/blood MH - Dose-Response Relationship, Drug MH - GABA Antagonists/pharmacology MH - GABA-B Receptor Antagonists MH - Injections, Intraventricular MH - Male MH - Organophosphorus Compounds/pharmacology MH - Picrotoxin/pharmacology MH - Receptors, GABA-B/*physiology MH - Stress, Psychological/physiopathology/*prevention & control MH - Vocalization, Animal/drug effects EDAT- 2006/02/07 09:00 MHDA- 2006/04/19 09:00 CRDT- 2006/02/07 09:00 PHST- 2005/06/27 00:00 [received] PHST- 2005/12/14 00:00 [revised] PHST- 2005/12/16 00:00 [accepted] PHST- 2006/02/07 09:00 [pubmed] PHST- 2006/04/19 09:00 [medline] PHST- 2006/02/07 09:00 [entrez] AID - S0014-2999(05)01326-9 [pii] AID - 10.1016/j.ejphar.2005.12.024 [doi] PST - ppublish SO - Eur J Pharmacol. 2006 Feb 15;531(1-3):171-5. doi: 10.1016/j.ejphar.2005.12.024. Epub 2006 Feb 2.